Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Keywords:
Tags: Current Focus,
Grouped Articles
Maker of Tylenol Explains Actions Taken to Alleviate Musty Smell of Pills
New York Times 03/17/2010
Wall Street Journal 05/18/2010
Questions for Makers on Defects in Drugs
New York Times 05/26/2010
Memos to J&J Gave Details Of Motrin Buys
Wall Street Journal 06/12/2010
J.&J. Unit Recalls Additional Over-the-Counter Drugs
New York Times 06/15/2010
Recall of Pills Fails to Give Number of Bottles
New York Times 07/08/2010
Grouped Articles
J&J Chief Tends Corporate Wounds
Wall Street Journal 08/30/2010
J&J's Quality Control Draws Scrutiny
Wall Street Journal 09/28/2010
Wall Street Journal 12/10/2010
Will Johnson & Johnson Recalls Change the Firmâs Reputation?
New York Times 01/15/2011
J&J Revamps McNeil Unit After Recalls
Wall Street Journal 03/31/2011
J.&J. to Buy Synthes for $21.3 Billion
New York Times 04/27/2011
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1